Minnesota's Senate Bill 2669, introduced on April 22, 2025, aims to reform the reimbursement structure for pharmacies, particularly focusing on the dispensing fees for prescription and over-the-counter drugs. The bill proposes a professional dispensing fee of $11.55 for prescriptions filled with covered outpatient drugs, with a prorated fee for quantities less than the manufacturer's original package. For over-the-counter drugs not classified as covered outpatient drugs, the fee is set at $3.65, also prorated based on the quantity dispensed.

One of the bill's key provisions is the establishment of a clear framework for determining the ingredient cost of drugs, utilizing the National Average Drug Acquisition Cost (NADAC), Minnesota Actual Acquisition Cost (MNAAC), or maximum allowable cost. This aims to ensure that pharmacies are fairly compensated while maintaining affordable drug prices for consumers. Additionally, the bill allows pharmacies serving long-term care facilities to implement retrospective billing, which would enable them to charge only for the quantity of medication actually used during a defined billing period.

The introduction of Senate Bill 2669 has sparked discussions among lawmakers and stakeholders in the healthcare sector. Supporters argue that the bill will enhance pharmacy sustainability and improve access to medications, particularly in underserved areas. However, some opposition has emerged, with concerns about the potential impact on drug pricing and the administrative burden on pharmacies.

The implications of this bill are significant, as it seeks to balance the financial viability of pharmacies with the need for affordable healthcare. Experts suggest that if passed, the bill could lead to more equitable pricing structures and improved medication access for Minnesota residents, particularly those in long-term care facilities.

As the legislative process unfolds, the future of Senate Bill 2669 will be closely monitored, with potential amendments and debates likely to shape its final form. The outcome could set a precedent for pharmacy reimbursement practices across the state, influencing how medications are dispensed and billed in Minnesota.